nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Dexamethasone—psoriatic arthritis	0.0949	0.158	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0949	0.158	CbGbCtD
Lercanidipine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0734	0.122	CbGbCtD
Lercanidipine—CYP3A5—Dexamethasone—psoriatic arthritis	0.0712	0.118	CbGbCtD
Lercanidipine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0556	0.0926	CbGbCtD
Lercanidipine—CYP3A4—Betamethasone—psoriatic arthritis	0.0477	0.0794	CbGbCtD
Lercanidipine—CYP3A4—Prednisolone—psoriatic arthritis	0.0471	0.0784	CbGbCtD
Lercanidipine—CYP3A4—Prednisone—psoriatic arthritis	0.0445	0.074	CbGbCtD
Lercanidipine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0437	0.0727	CbGbCtD
Lercanidipine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0278	0.0462	CbGbCtD
Lercanidipine—Myalgia—Triamcinolone—psoriatic arthritis	0.000648	0.00162	CcSEcCtD
Lercanidipine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000646	0.00162	CcSEcCtD
Lercanidipine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000646	0.00162	CcSEcCtD
Lercanidipine—Eye disorder—Prednisone—psoriatic arthritis	0.000645	0.00162	CcSEcCtD
Lercanidipine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000644	0.00161	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000642	0.00161	CcSEcCtD
Lercanidipine—Flushing—Prednisone—psoriatic arthritis	0.000641	0.00161	CcSEcCtD
Lercanidipine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00064	0.0016	CcSEcCtD
Lercanidipine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00064	0.0016	CcSEcCtD
Lercanidipine—Discomfort—Triamcinolone—psoriatic arthritis	0.00064	0.0016	CcSEcCtD
Lercanidipine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000638	0.0016	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000637	0.0016	CcSEcCtD
Lercanidipine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000633	0.00159	CcSEcCtD
Lercanidipine—Renal failure—Methotrexate—psoriatic arthritis	0.000632	0.00158	CcSEcCtD
Lercanidipine—Angioedema—Dexamethasone—psoriatic arthritis	0.000631	0.00158	CcSEcCtD
Lercanidipine—Angioedema—Betamethasone—psoriatic arthritis	0.000631	0.00158	CcSEcCtD
Lercanidipine—Stomatitis—Methotrexate—psoriatic arthritis	0.000627	0.00157	CcSEcCtD
Lercanidipine—Angiopathy—Prednisone—psoriatic arthritis	0.000626	0.00157	CcSEcCtD
Lercanidipine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000625	0.00156	CcSEcCtD
Lercanidipine—Immune system disorder—Prednisone—psoriatic arthritis	0.000624	0.00156	CcSEcCtD
Lercanidipine—Malaise—Betamethasone—psoriatic arthritis	0.000622	0.00156	CcSEcCtD
Lercanidipine—Malaise—Dexamethasone—psoriatic arthritis	0.000622	0.00156	CcSEcCtD
Lercanidipine—Vertigo—Dexamethasone—psoriatic arthritis	0.00062	0.00155	CcSEcCtD
Lercanidipine—Vertigo—Betamethasone—psoriatic arthritis	0.00062	0.00155	CcSEcCtD
Lercanidipine—Syncope—Dexamethasone—psoriatic arthritis	0.000619	0.00155	CcSEcCtD
Lercanidipine—Syncope—Betamethasone—psoriatic arthritis	0.000619	0.00155	CcSEcCtD
Lercanidipine—Shock—Triamcinolone—psoriatic arthritis	0.000611	0.00153	CcSEcCtD
Lercanidipine—Insomnia—Prednisolone—psoriatic arthritis	0.000611	0.00153	CcSEcCtD
Lercanidipine—Alopecia—Prednisone—psoriatic arthritis	0.00061	0.00153	CcSEcCtD
Lercanidipine—Shock—Methylprednisolone—psoriatic arthritis	0.000609	0.00153	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000608	0.00152	CcSEcCtD
Lercanidipine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000607	0.00152	CcSEcCtD
Lercanidipine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000607	0.00152	CcSEcCtD
Lercanidipine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000607	0.00152	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000606	0.00152	CcSEcCtD
Lercanidipine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000606	0.00152	CcSEcCtD
Lercanidipine—Mental disorder—Prednisone—psoriatic arthritis	0.000605	0.00152	CcSEcCtD
Lercanidipine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000605	0.00151	CcSEcCtD
Lercanidipine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000602	0.00151	CcSEcCtD
Lercanidipine—Erythema—Prednisone—psoriatic arthritis	0.000601	0.00151	CcSEcCtD
Lercanidipine—Malnutrition—Prednisone—psoriatic arthritis	0.000601	0.00151	CcSEcCtD
Lercanidipine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.0006	0.0015	CcSEcCtD
Lercanidipine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.0006	0.0015	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000599	0.0015	CcSEcCtD
Lercanidipine—Myalgia—Betamethasone—psoriatic arthritis	0.000588	0.00147	CcSEcCtD
Lercanidipine—Myalgia—Dexamethasone—psoriatic arthritis	0.000588	0.00147	CcSEcCtD
Lercanidipine—Anxiety—Betamethasone—psoriatic arthritis	0.000586	0.00147	CcSEcCtD
Lercanidipine—Anxiety—Dexamethasone—psoriatic arthritis	0.000586	0.00147	CcSEcCtD
Lercanidipine—Discomfort—Dexamethasone—psoriatic arthritis	0.000581	0.00145	CcSEcCtD
Lercanidipine—Discomfort—Betamethasone—psoriatic arthritis	0.000581	0.00145	CcSEcCtD
Lercanidipine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000579	0.00145	CcSEcCtD
Lercanidipine—Hepatitis—Methotrexate—psoriatic arthritis	0.000577	0.00145	CcSEcCtD
Lercanidipine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00057	0.00143	CcSEcCtD
Lercanidipine—Vision blurred—Prednisone—psoriatic arthritis	0.000566	0.00142	CcSEcCtD
Lercanidipine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000566	0.00142	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000566	0.00142	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000564	0.00141	CcSEcCtD
Lercanidipine—Insomnia—Triamcinolone—psoriatic arthritis	0.000561	0.00141	CcSEcCtD
Lercanidipine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00056	0.0014	CcSEcCtD
Lercanidipine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000558	0.0014	CcSEcCtD
Lercanidipine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000557	0.0014	CcSEcCtD
Lercanidipine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000556	0.00139	CcSEcCtD
Lercanidipine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000556	0.00139	CcSEcCtD
Lercanidipine—Anaemia—Prednisone—psoriatic arthritis	0.000556	0.00139	CcSEcCtD
Lercanidipine—Shock—Dexamethasone—psoriatic arthritis	0.000554	0.00139	CcSEcCtD
Lercanidipine—Shock—Betamethasone—psoriatic arthritis	0.000554	0.00139	CcSEcCtD
Lercanidipine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000553	0.00139	CcSEcCtD
Lercanidipine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000552	0.00138	CcSEcCtD
Lercanidipine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000552	0.00138	CcSEcCtD
Lercanidipine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000551	0.00138	CcSEcCtD
Lercanidipine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000551	0.00138	CcSEcCtD
Lercanidipine—Tachycardia—Betamethasone—psoriatic arthritis	0.00055	0.00138	CcSEcCtD
Lercanidipine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00055	0.00138	CcSEcCtD
Lercanidipine—Angioedema—Prednisone—psoriatic arthritis	0.000549	0.00138	CcSEcCtD
Lercanidipine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000546	0.00137	CcSEcCtD
Lercanidipine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000546	0.00137	CcSEcCtD
Lercanidipine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000545	0.00137	CcSEcCtD
Lercanidipine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000545	0.00136	CcSEcCtD
Lercanidipine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000545	0.00136	CcSEcCtD
Lercanidipine—Malaise—Prednisone—psoriatic arthritis	0.000542	0.00136	CcSEcCtD
Lercanidipine—Vertigo—Prednisone—psoriatic arthritis	0.00054	0.00135	CcSEcCtD
Lercanidipine—Eye disorder—Methotrexate—psoriatic arthritis	0.000539	0.00135	CcSEcCtD
Lercanidipine—Syncope—Prednisone—psoriatic arthritis	0.000539	0.00135	CcSEcCtD
Lercanidipine—Tinnitus—Methotrexate—psoriatic arthritis	0.000538	0.00135	CcSEcCtD
Lercanidipine—Anorexia—Dexamethasone—psoriatic arthritis	0.000537	0.00135	CcSEcCtD
Lercanidipine—Anorexia—Betamethasone—psoriatic arthritis	0.000537	0.00135	CcSEcCtD
Lercanidipine—Urticaria—Prednisolone—psoriatic arthritis	0.000536	0.00134	CcSEcCtD
Lercanidipine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000536	0.00134	CcSEcCtD
Lercanidipine—Fatigue—Triamcinolone—psoriatic arthritis	0.000535	0.00134	CcSEcCtD
Lercanidipine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000534	0.00134	CcSEcCtD
Lercanidipine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000528	0.00132	CcSEcCtD
Lercanidipine—Hypotension—Betamethasone—psoriatic arthritis	0.000526	0.00132	CcSEcCtD
Lercanidipine—Hypotension—Dexamethasone—psoriatic arthritis	0.000526	0.00132	CcSEcCtD
Lercanidipine—Angiopathy—Methotrexate—psoriatic arthritis	0.000524	0.00131	CcSEcCtD
Lercanidipine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000521	0.00131	CcSEcCtD
Lercanidipine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00052	0.0013	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000513	0.00129	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000513	0.00129	CcSEcCtD
Lercanidipine—Myalgia—Prednisone—psoriatic arthritis	0.000512	0.00128	CcSEcCtD
Lercanidipine—Arthralgia—Prednisone—psoriatic arthritis	0.000512	0.00128	CcSEcCtD
Lercanidipine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000512	0.00128	CcSEcCtD
Lercanidipine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00051	0.00128	CcSEcCtD
Lercanidipine—Anxiety—Prednisone—psoriatic arthritis	0.00051	0.00128	CcSEcCtD
Lercanidipine—Alopecia—Methotrexate—psoriatic arthritis	0.00051	0.00128	CcSEcCtD
Lercanidipine—Insomnia—Dexamethasone—psoriatic arthritis	0.000509	0.00128	CcSEcCtD
Lercanidipine—Insomnia—Betamethasone—psoriatic arthritis	0.000509	0.00128	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000508	0.00127	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000506	0.00127	CcSEcCtD
Lercanidipine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000506	0.00127	CcSEcCtD
Lercanidipine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000506	0.00127	CcSEcCtD
Lercanidipine—Discomfort—Prednisone—psoriatic arthritis	0.000506	0.00127	CcSEcCtD
Lercanidipine—Mental disorder—Methotrexate—psoriatic arthritis	0.000506	0.00127	CcSEcCtD
Lercanidipine—Erythema—Methotrexate—psoriatic arthritis	0.000502	0.00126	CcSEcCtD
Lercanidipine—Malnutrition—Methotrexate—psoriatic arthritis	0.000502	0.00126	CcSEcCtD
Lercanidipine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000497	0.00125	CcSEcCtD
Lercanidipine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000496	0.00124	CcSEcCtD
Lercanidipine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000496	0.00124	CcSEcCtD
Lercanidipine—Urticaria—Triamcinolone—psoriatic arthritis	0.000493	0.00124	CcSEcCtD
Lercanidipine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000492	0.00123	CcSEcCtD
Lercanidipine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000492	0.00123	CcSEcCtD
Lercanidipine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000491	0.00123	CcSEcCtD
Lercanidipine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00049	0.00123	CcSEcCtD
Lercanidipine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00049	0.00123	CcSEcCtD
Lercanidipine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00049	0.00123	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000486	0.00122	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000486	0.00122	CcSEcCtD
Lercanidipine—Fatigue—Dexamethasone—psoriatic arthritis	0.000486	0.00122	CcSEcCtD
Lercanidipine—Fatigue—Betamethasone—psoriatic arthritis	0.000486	0.00122	CcSEcCtD
Lercanidipine—Shock—Prednisone—psoriatic arthritis	0.000483	0.00121	CcSEcCtD
Lercanidipine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000481	0.00121	CcSEcCtD
Lercanidipine—Tachycardia—Prednisone—psoriatic arthritis	0.000479	0.0012	CcSEcCtD
Lercanidipine—Skin disorder—Prednisone—psoriatic arthritis	0.000476	0.00119	CcSEcCtD
Lercanidipine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000474	0.00119	CcSEcCtD
Lercanidipine—Vision blurred—Methotrexate—psoriatic arthritis	0.000473	0.00119	CcSEcCtD
Lercanidipine—Anorexia—Prednisone—psoriatic arthritis	0.000468	0.00117	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000466	0.00117	CcSEcCtD
Lercanidipine—Anaemia—Methotrexate—psoriatic arthritis	0.000464	0.00116	CcSEcCtD
Lercanidipine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000464	0.00116	CcSEcCtD
Lercanidipine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000464	0.00116	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000461	0.00115	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000461	0.00115	CcSEcCtD
Lercanidipine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000457	0.00115	CcSEcCtD
Lercanidipine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000456	0.00114	CcSEcCtD
Lercanidipine—Malaise—Methotrexate—psoriatic arthritis	0.000453	0.00113	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—psoriatic arthritis	0.000451	0.00113	CcSEcCtD
Lercanidipine—Urticaria—Betamethasone—psoriatic arthritis	0.000447	0.00112	CcSEcCtD
Lercanidipine—Urticaria—Dexamethasone—psoriatic arthritis	0.000447	0.00112	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000447	0.00112	CcSEcCtD
Lercanidipine—Dizziness—Prednisolone—psoriatic arthritis	0.000446	0.00112	CcSEcCtD
Lercanidipine—Asthenia—Triamcinolone—psoriatic arthritis	0.000445	0.00112	CcSEcCtD
Lercanidipine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000445	0.00112	CcSEcCtD
Lercanidipine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000445	0.00112	CcSEcCtD
Lercanidipine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000445	0.00112	CcSEcCtD
Lercanidipine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000445	0.00112	CcSEcCtD
Lercanidipine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000444	0.00111	CcSEcCtD
Lercanidipine—Insomnia—Prednisone—psoriatic arthritis	0.000444	0.00111	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisone—psoriatic arthritis	0.00044	0.0011	CcSEcCtD
Lercanidipine—Pruritus—Triamcinolone—psoriatic arthritis	0.000439	0.0011	CcSEcCtD
Lercanidipine—Cough—Methotrexate—psoriatic arthritis	0.000438	0.0011	CcSEcCtD
Lercanidipine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000438	0.0011	CcSEcCtD
Lercanidipine—Dyspepsia—Prednisone—psoriatic arthritis	0.000432	0.00108	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—psoriatic arthritis	0.000428	0.00107	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—psoriatic arthritis	0.000428	0.00107	CcSEcCtD
Lercanidipine—Myalgia—Methotrexate—psoriatic arthritis	0.000428	0.00107	CcSEcCtD
Lercanidipine—Decreased appetite—Prednisone—psoriatic arthritis	0.000426	0.00107	CcSEcCtD
Lercanidipine—Rash—Prednisolone—psoriatic arthritis	0.000426	0.00107	CcSEcCtD
Lercanidipine—Dermatitis—Prednisolone—psoriatic arthritis	0.000425	0.00107	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000425	0.00106	CcSEcCtD
Lercanidipine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000424	0.00106	CcSEcCtD
Lercanidipine—Fatigue—Prednisone—psoriatic arthritis	0.000423	0.00106	CcSEcCtD
Lercanidipine—Headache—Prednisolone—psoriatic arthritis	0.000423	0.00106	CcSEcCtD
Lercanidipine—Discomfort—Methotrexate—psoriatic arthritis	0.000423	0.00106	CcSEcCtD
Lercanidipine—Constipation—Prednisone—psoriatic arthritis	0.000419	0.00105	CcSEcCtD
Lercanidipine—Confusional state—Methotrexate—psoriatic arthritis	0.000413	0.00104	CcSEcCtD
Lercanidipine—Dizziness—Triamcinolone—psoriatic arthritis	0.00041	0.00103	CcSEcCtD
Lercanidipine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00041	0.00103	CcSEcCtD
Lercanidipine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000404	0.00101	CcSEcCtD
Lercanidipine—Asthenia—Betamethasone—psoriatic arthritis	0.000404	0.00101	CcSEcCtD
Lercanidipine—Asthenia—Dexamethasone—psoriatic arthritis	0.000404	0.00101	CcSEcCtD
Lercanidipine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000402	0.00101	CcSEcCtD
Lercanidipine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000401	0.00101	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000401	0.00101	CcSEcCtD
Lercanidipine—Nausea—Prednisolone—psoriatic arthritis	0.000401	0.001	CcSEcCtD
Lercanidipine—Pruritus—Betamethasone—psoriatic arthritis	0.000399	0.000998	CcSEcCtD
Lercanidipine—Pruritus—Dexamethasone—psoriatic arthritis	0.000399	0.000998	CcSEcCtD
Lercanidipine—Skin disorder—Methotrexate—psoriatic arthritis	0.000398	0.000998	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000396	0.000993	CcSEcCtD
Lercanidipine—Vomiting—Triamcinolone—psoriatic arthritis	0.000395	0.000989	CcSEcCtD
Lercanidipine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000394	0.000987	CcSEcCtD
Lercanidipine—Rash—Triamcinolone—psoriatic arthritis	0.000391	0.000981	CcSEcCtD
Lercanidipine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000391	0.00098	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—psoriatic arthritis	0.000391	0.000979	CcSEcCtD
Lercanidipine—Rash—Methylprednisolone—psoriatic arthritis	0.000391	0.000979	CcSEcCtD
Lercanidipine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00039	0.000978	CcSEcCtD
Lercanidipine—Urticaria—Prednisone—psoriatic arthritis	0.00039	0.000976	CcSEcCtD
Lercanidipine—Headache—Triamcinolone—psoriatic arthritis	0.000389	0.000974	CcSEcCtD
Lercanidipine—Headache—Methylprednisolone—psoriatic arthritis	0.000388	0.000972	CcSEcCtD
Lercanidipine—Body temperature increased—Prednisone—psoriatic arthritis	0.000388	0.000972	CcSEcCtD
Lercanidipine—Abdominal pain—Prednisone—psoriatic arthritis	0.000388	0.000972	CcSEcCtD
Lercanidipine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000385	0.000966	CcSEcCtD
Lercanidipine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000385	0.000966	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—psoriatic arthritis	0.000383	0.00096	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000373	0.000936	CcSEcCtD
Lercanidipine—Dizziness—Dexamethasone—psoriatic arthritis	0.000372	0.000933	CcSEcCtD
Lercanidipine—Dizziness—Betamethasone—psoriatic arthritis	0.000372	0.000933	CcSEcCtD
Lercanidipine—Insomnia—Methotrexate—psoriatic arthritis	0.000371	0.000929	CcSEcCtD
Lercanidipine—Nausea—Triamcinolone—psoriatic arthritis	0.000369	0.000924	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000368	0.000922	CcSEcCtD
Lercanidipine—Nausea—Methylprednisolone—psoriatic arthritis	0.000368	0.000922	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000365	0.000916	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—psoriatic arthritis	0.000364	0.000913	CcSEcCtD
Lercanidipine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000361	0.000906	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000361	0.000904	CcSEcCtD
Lercanidipine—Vomiting—Betamethasone—psoriatic arthritis	0.000358	0.000897	CcSEcCtD
Lercanidipine—Vomiting—Dexamethasone—psoriatic arthritis	0.000358	0.000897	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000356	0.000893	CcSEcCtD
Lercanidipine—Rash—Betamethasone—psoriatic arthritis	0.000355	0.00089	CcSEcCtD
Lercanidipine—Rash—Dexamethasone—psoriatic arthritis	0.000355	0.00089	CcSEcCtD
Lercanidipine—Dermatitis—Betamethasone—psoriatic arthritis	0.000355	0.000889	CcSEcCtD
Lercanidipine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000355	0.000889	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000354	0.000887	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—psoriatic arthritis	0.000353	0.000886	CcSEcCtD
Lercanidipine—Headache—Betamethasone—psoriatic arthritis	0.000353	0.000884	CcSEcCtD
Lercanidipine—Headache—Dexamethasone—psoriatic arthritis	0.000353	0.000884	CcSEcCtD
Lercanidipine—Asthenia—Prednisone—psoriatic arthritis	0.000352	0.000882	CcSEcCtD
Lercanidipine—Pruritus—Prednisone—psoriatic arthritis	0.000347	0.00087	CcSEcCtD
Lercanidipine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000338	0.000846	CcSEcCtD
Lercanidipine—Diarrhoea—Prednisone—psoriatic arthritis	0.000336	0.000841	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000335	0.00084	CcSEcCtD
Lercanidipine—Nausea—Dexamethasone—psoriatic arthritis	0.000335	0.000838	CcSEcCtD
Lercanidipine—Nausea—Betamethasone—psoriatic arthritis	0.000335	0.000838	CcSEcCtD
Lercanidipine—Urticaria—Methotrexate—psoriatic arthritis	0.000326	0.000816	CcSEcCtD
Lercanidipine—Dizziness—Prednisone—psoriatic arthritis	0.000324	0.000813	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000324	0.000812	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000324	0.000812	CcSEcCtD
Lercanidipine—Vomiting—Prednisone—psoriatic arthritis	0.000312	0.000781	CcSEcCtD
Lercanidipine—Rash—Prednisone—psoriatic arthritis	0.000309	0.000775	CcSEcCtD
Lercanidipine—Dermatitis—Prednisone—psoriatic arthritis	0.000309	0.000774	CcSEcCtD
Lercanidipine—Headache—Prednisone—psoriatic arthritis	0.000307	0.00077	CcSEcCtD
Lercanidipine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000302	0.000757	CcSEcCtD
Lercanidipine—Asthenia—Methotrexate—psoriatic arthritis	0.000294	0.000737	CcSEcCtD
Lercanidipine—Nausea—Prednisone—psoriatic arthritis	0.000291	0.00073	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—psoriatic arthritis	0.00029	0.000727	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—psoriatic arthritis	0.00028	0.000703	CcSEcCtD
Lercanidipine—Dizziness—Methotrexate—psoriatic arthritis	0.000271	0.000679	CcSEcCtD
Lercanidipine—Vomiting—Methotrexate—psoriatic arthritis	0.000261	0.000653	CcSEcCtD
Lercanidipine—Rash—Methotrexate—psoriatic arthritis	0.000258	0.000648	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—psoriatic arthritis	0.000258	0.000647	CcSEcCtD
Lercanidipine—Headache—Methotrexate—psoriatic arthritis	0.000257	0.000643	CcSEcCtD
Lercanidipine—Nausea—Methotrexate—psoriatic arthritis	0.000244	0.00061	CcSEcCtD
